As consumer technology continues to advance, wearable or portable smart devices are becoming increasingly accessible, contributing to the rapid emergence of digital biomarkers in modern healthcare, as well as a...
Read More
The finger tap test is one of the oldest and most widely used motor assessments in clinical neuroscience. A clinician watches a patient tap as quickly as possible for a...
Read More
Diversity in clinical trials is not only a social imperative, it is a scientific standard. February, during Black History Month, offers an important moment to reflect on both the historical...
Read More
Clinical development has never had more tools at its disposal. Wearables, sensors, mobile apps, imaging, biomarkers, and real-world data streams are increasingly used to generate digital endpoints in clinical trials,...
Read More
We are happy to announce that our clinical study KH007 (NCT06219629) of Disease Progression in Parkinson's Disease (PD) achieved the last patient in (LPI) on January 10, 2025. This is...
Read More
Dear Friends, As the year comes to a close, we are grateful for the progress we have made toward our vision of developing digital measures that benefit patients and are...
Read More
In the same week that the Michael J. Fox Foundation (MJFF) held its 14th annual Parkinson’s Disease (PD) Therapeutics Conference in New York City, Koneksa held its inaugural PD Day....
Read More
This year’s International Parkinson and Movement Disorder Society (MDS) was held over the last weekend of September in Philadelphia. The theme, “Movement Disorders in the Digital Age: Harnessing AI for...
Read More
We were privileged to attend the 7th Annual Digital Biomarkers in Clinical Trials Summit at the Roche Headquarters in Basel on June 26th, 2024. Over 300 attendees attended the consortium,...
Read More
Last week, two important events happened, both hosted by the Critical Path Institute (C-Path): the Electronic Clinical Outcome Assessment (eCOA) Consortium meeting on April 16, and the 2024 Clinical Outcome...
Read More
